-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
As of December 23, 2020, 1893,360 people in the U.S. had received the first dose of Pfizer's new crown vaccine, and 4,393 adverse reactions (about 0.2 percent of adverse reactions) were reported, including 21 allergic reactions, according to a report released By the U.S. Centers for Disease Control and Prevention on Dec. 23, 2020.
U.S. Food and Drug Administration approved in December 2020 an emergency authorization application for a new crown vaccine jointly developed by Pfizer Pharmaceuticals Inc. and German Biotech.
this is the first new crown vaccine approved for emergency use in the United States, allowed for people 16 years and older, a total of two doses, 21 days apart.
, according to the U.S. Centers for Disease Control and Prevention and the U.S. Drug Administration website, the vaccine in previous clinical trials appeared adverse reactions include local redness, headache, fatigue and so on.
reported allergic reactions after the vaccine was started in the United States, the United Kingdom and other countries.
the UK's drug regulator has previously said it has issued preventive advice to health authorities that no one should be vaccinated against a "significant" allergic reaction to a drug, food or vaccine.
The U.S. Centers for Disease Control and Prevention said in a report on the 6th, the new crown vaccination point needs to strictly comply with the CDC's requirements for new crown vaccination, including screening for vaccination taboos, to prepare for allergic reactions, after vaccination of the situation to observe.
currently, two new crown vaccines have been approved for emergency use by the U.S. Drug Administration, in addition to the vaccine jointly developed by Pfizer and German bio-technology companies, and the other by The United States Modner.
vaccines have been distributed across the United States, giving priority to health care workers and people living in long-term care facilities such as nursing homes.
January 6, 2021, nearly 17.289 million doses of the vaccine had been distributed across the United States, with about 5.306 million people getting the first dose, according to the CDC's website.
Tan Jingjing Source: Xinhua News Agency Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Metz Medical and are not authorized to be reproduced by any media, website or individual, and must be reproduced with the words "Source: Mes Medicine".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
at the same time reproduced content does not represent the position of this site.
leave a message here